Torigen Pharmaceuticals is focused on veterinary cancer care. Their product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment that educates the immune system to recognize the tumor as foreign. 

Veterinary & Pet

Torigen Pharmaceuticals

Ashley Kalinauskas

Troy Gobbett, PMP

Kathryn Deeley

John Kallassy

Christine McCoy

Chelsea Greenberg

Mark Suckow

Michael Lucroy

Sean Fitzgerald

Ryan Clauson

The Research and Development team at Torigen Pharmaceuticals is dedicated to advancing innovative cancer therapies for veterinary care. They spearhead the development of VetiVax by conducting scientific research, managing clinical trials, and ensuring operational excellence, all while collaborating with external partners to drive groundbreaking discoveries in immunotherapy for pets.

Research and Development

Sales and Business Development

Leadership Team

Research and Development

About

Team members

Other teams at Torigen Pharmaceuticals

Sales and Business Development

Leadership Team